High glucose alters cardiomyocyte contacts and inhibits myofibrillar formation

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 5, 2006, Pages 1961-1967

  Dyntar, Daniela ^a   Sergeev, Pavel ^b   Klisic, Jelena ^a   Ambühl, Patrice ^a   Schaub, Marcus C ^b   Donath, Marc Y ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; GLUCOSE; MYOSIN HEAVY CHAIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL CONTACT; CELL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HEART MUSCLE CELL; MUSCLE FIBER CONTRACTION; MUSCLE FIBRIL; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOMERE; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CELL COMMUNICATION; CELL SIZE; CELLS, CULTURED; DEOXYGLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE; HEART VENTRICLES; IMMUNOHISTOCHEMISTRY; MYOCYTES, CARDIAC; MYOFIBRILS; ORGAN SIZE; OXIDATIVE STRESS; RATS;

ANIMALIA;

EID: 33646392457     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1904     Document Type: Article

References (37)

1. LeWinter MM 1996 Diabetic cardiomyopathy: an overview. Coron Artery Dis 7:95-98
2. Spector KS 1998 Diabetic cardiomyopathy. Clin Cardiol 21:885-887
3. Bertoni AG, Tsai A, Kasper EK, Brancati FL 2003 Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 26:2791-2795
4. Adeghate E 2004 Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review. Mol Cell Biochem 261:187-191
5. Hayat SA, Patel B, Khattar RS, Malik RA 2004 Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 107:539-557
6. De Vries JE, Vork MM, Roemen TH, De Jong YF, Cleutjens JP, Van Der Vusse GJ, van Bilsen M 1997 Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 38:1384-1394
7. Malhotra A, Sanghi V 1997 Regulation of contractile proteins in diabetic heart. Cardiovasc Res 34:34-40
8. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P 1997 Apoptosis in the failing human heart. N Engl J Med 336:1131-1141
9. Hickson-Bick DL, Buja ML, McMillin JB 2000 Palmitate-mediated alterations in the fatty acid metabolism of rat neonatal cardiac myocytes. J Mol Cell Cardiol 32:511-519
10. Sparagna GC, Hickson-Bick DL, Buja LM, McMillin JB 2000Ametabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol 279:H2124-H2132
11. Dyntar D, Eppenberger-Eberhardt M, Maedler K, Pruschy M, Eppenberger HM, Spinas GA, Donath MY 2001 Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes 50:2105-2113
12. Fiordaliso F, Bianchi R, Staszewsky L, Cuccovillo I, Doni M, Laragione T, Salio M, Savino C, Melucci S, Santangelo F, Scanziani E, Masson S, Ghezzi P, Latini R 2004 Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 37:959-968
13. Shinde UA, Goyal RK 2003 Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats. J Cell Mol Med 7:322-329
14. Gerdes AM, Onodera T, Tamura T, Said S, Bohlmeyer TJ, Abraham WT, Bristow MR 1998 New method to evaluate myocyte remodeling from formalin-fixed biopsy and autopsy material. J Card Fail 4:343-348
15. Donath MY, Zapf J, Eppenberger-Eberhardt M, Froesch ER, Eppenberger HM 1994 Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle α-actin of adult cardiomyocytes. Proc Natl Acad Sci USA 91:1686-1690
16. Isenberg G, Klockner U 1982 Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium." Pflugers Arch 395:6-18
17. Harder BA, Schaub MC, Eppenberger HM, Eppenberger-Eberhardt M 1996 Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture. J Mol Cell Cardiol 28:19-31
18. Da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M 2004 Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning. Anesthesia 100:59-69
19. Grove BK, Kurer V, Lehner C, Doetschman TC, Perriard JC, Eppenberger HM 1984 A new 185,000-dalton skeletal muscle protein detected by monoclonal antibodies. J Cell Biol 98:518-524
20. Donath MY, Gross DJ, Cerasi E, Kaiser N 1999 Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738-744
21. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY 2002 Glucose-induced β-cell production of interleukin-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860
22. Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J 2000 Myocyte death in streptozotocin-induced diabetes in rats is angiotensin-II-dependent. Lab Invest 80:513-527
23. Makino H, Mukoyama M, Sugawara A, Mori K, Suganami T, Yahata K, Fujinaga Y, Yokoi H, Tanaka I, Nakao K 2003 Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effects of aspirin treatment. Clin Exp Nephrol 7:33-40
24. Harder BA, Hefti MA, Eppenberger HM, Schaub MC 1998 Differential protein localization in sarcomeric and nonsarcomeric contractile structures of cultured cardiomyocytes. J Struct Biol 122:162-175
25. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM 1998 Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 4:1421-1424
26. Schiaffino S, Reggiani C 1996 Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 76:371-423
27. Stavinoha MA, Ray Spellicy JW, Essop MF, Graveleau C, Abel ED, Hart-Sailors ML, Mersmann HJ, Bray MS, Young ME 2004 Evidence for mitochondrial thioesterase-1 as a peroxisome proliferator-activated receptor-α-regulated gene in cardiac and skeletal muscle. Am J Physiol 287:E888-E895
28. Akazawa H, Komuro I 2003 Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92:1079-1088
29. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH 2000 Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97:1784-1789
30. Garg S, Narula J, Chandrashekhar Y 2005 Apoptosis and heart failure: clinical relevance and therapeutic target. J Mol Cell Cardiol 38:73-79
31. Donath MY, Halban PA 2004 Decreased β-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47:581-589
32. Schaub MC, Hefti MA, Harder BA, Eppenberger HM 1997 Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med 75:901-920
33. Anversa P, Nadal-Ginard B 2002 Myocyte renewal and ventricular remodeling. Nature 415:240-243
34. Zaugg M, Schaub MC 2003 Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning. J Muscle Res Cell Motil 24:219-249
35. Des Tombe AL, van Beek-Harmsen BJ, Lee-De Groot MBE, Van Der Larse WJ 2002 Calibrated histochemistry applied to oxygen supply and demand in hypertrophied rat myocardium. Microsc Res Tech 58:412-420
36. Ilangovan G, Liebgott T, Kutala VK, Petryakov S 2004 EPR oximetry in the beating heart: myocardial oxygen consumption rate as an index of postischemic recovery. Magn Reson Med 51:835-842
37. Teunissen BEJ, Jongsma HJ, Bierhuizen MFA 2004 Regulation of myocardial connexins during hypertrophic remodelling. Eur Heart J 25:1979-1989